Development of new cobalt, copper, and zinc complexes of Schiff-base ligands as prospective chemotherapeutic agents

化学 席夫碱 八面体分子几何学 配体(生物化学) 齿合度 Knoevenagel冷凝 抗坏血酸 核化学 质子核磁共振 药物化学 无机化学 立体化学 金属 有机化学 受体 催化作用 生物化学 食品科学
作者
V. Narayanan,A. Rajendran,Srikrishna Mudradi,Soven Dhawa,Sreeja Rajendran,Kondapa Naidu Bobba,Jeya Rajendran,Prasanna Ramani
出处
期刊:Polyhedron [Elsevier BV]
卷期号:245: 116622-116622
标识
DOI:10.1016/j.poly.2023.116622
摘要

Fluorobenzaldehyde was converted into new, bidentate Schiff-base ligands with nitrogen and sulphur donor sites in two steps. The first step proceeds via Knoevenagel condensation; the product obtained was treated with thiosemicarbazide to yield the ligand L1. The Schiff-base ligand, L2, was synthesized by treating L1 with 4-chlorobenzylchloride in a basic medium. Co (II), Cu (II), and Zn (II) complexes were synthesized with the ligands L1 and L2. All these complexes were characterized by FTIR, UV–Vis, NMR spectroscopy, ESI-mass spectral analysis, magnetic moment, molar conductance, thermal, powder XRD, and electrochemical studies. From these studies, the molecular formulae of the complexes were found to be [M(L)2Cl2], where M = Co (II), Cu (II) and Zn (II) and L = L1 or L2 based on the ligand used in the synthesis. The synthesized complexes were observed to have a high spin and distorted octahedral geometry and were non-electrolytic. The UV absorption titrimetric analysis confirmed that these complexes would bind strongly to CT-DNA through the intercalative mode. The electrophorograms supported the statement that Cu (II) complexes could effectively catalyze the hydrolytic cleavage of CT-DNA and can be considered potent metallonuclease agents. The DPPH assay determined the antioxidant properties of these complexes, and the cupric complexes were observed to possess better antioxidant properties than the standard used ascorbic acid. The cell viability analysis of these complexes showed an elevated control of proliferation against a human breast adenocarcinoma (MCF-7) cancer cell line compared to a human cervical carcinoma (HeLa) cell line. The results exhibited by these compounds were compared with the standard drug, cisplatin. The binding affinity of the Cu (II) metal ion complex towards CT-DNA was high when compared to Co (II) and Zn (II) metal ions. These results are in line with the cytotoxicity studies. Molecular docking studies also hold up the experimental data. Cu (II) complexes using ligand L2 show higher efficiency than those with ligand L1 in all biological assays and can be considered a potent DNA-targeting drug.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
欧阳慕山完成签到,获得积分10
1秒前
满意尔安完成签到,获得积分0
1秒前
初学者完成签到,获得积分10
1秒前
意忆完成签到,获得积分10
1秒前
青青草完成签到,获得积分10
1秒前
卫夜天完成签到 ,获得积分10
2秒前
小章鱼完成签到,获得积分10
2秒前
2秒前
华国锋应助Rae采纳,获得20
3秒前
溪水完成签到 ,获得积分10
3秒前
尘埃之影完成签到,获得积分10
4秒前
罗大大完成签到 ,获得积分10
4秒前
秦111完成签到 ,获得积分10
4秒前
Maerang完成签到,获得积分10
4秒前
洋洋完成签到,获得积分20
4秒前
李雨完成签到,获得积分10
4秒前
tRNA完成签到,获得积分10
5秒前
hope完成签到,获得积分10
5秒前
hdd完成签到,获得积分10
5秒前
明朗完成签到,获得积分10
7秒前
学习猴完成签到,获得积分10
7秒前
熬夜的桃子给熬夜的桃子的求助进行了留言
7秒前
Youth完成签到,获得积分10
8秒前
8秒前
zzzzz完成签到,获得积分10
9秒前
点凌蝶完成签到,获得积分10
9秒前
ifast完成签到 ,获得积分10
9秒前
小白完成签到 ,获得积分10
9秒前
廖无极完成签到 ,获得积分10
10秒前
10秒前
10秒前
mlle完成签到,获得积分10
10秒前
西瓜以亦完成签到 ,获得积分10
10秒前
欣晴完成签到,获得积分10
11秒前
小苹果完成签到,获得积分10
11秒前
撒啊完成签到,获得积分10
11秒前
锅锅完成签到,获得积分20
11秒前
ChiariRay发布了新的文献求助20
12秒前
陈艺鹏完成签到,获得积分10
12秒前
yy完成签到,获得积分10
12秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
Immigrant Incorporation in East Asian Democracies 600
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3968608
求助须知:如何正确求助?哪些是违规求助? 3513486
关于积分的说明 11168243
捐赠科研通 3248926
什么是DOI,文献DOI怎么找? 1794540
邀请新用户注册赠送积分活动 875188
科研通“疑难数据库(出版商)”最低求助积分说明 804676